Published guidance, NICE advice and quality standards | Guidance

Showing 331 to 340 of 1898

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)	TA841	22 November 2022	22 November 2022
Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal)	TA842	22 November 2022	22 November 2022
Ab interno canaloplasty for open-angle glaucoma	IPG745	22 November 2022	22 November 2022
Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids (terminated appraisal)	TA839	16 November 2022	16 November 2022
Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal)	TA840	16 November 2022	16 November 2022
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules	IPG743	16 November 2022	16 November 2022
Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder	IPG742	9 November 2022	9 November 2022
Advocacy services for adults with health and social care needs	NG227	9 November 2022	9 November 2022
Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis (terminated appraisal)	TA838	2 November 2022	2 November 2022
Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanoma	TA837	26 October 2022	26 October 2022